Health News

4 noticeable health technology financing ads in May

This gathering is intended to highlight some of the most notable financing cycles of the month and is not intended to be complete.

Health technology companies have made several major financing announcements in May. Here is a list of some of the largest financing rounds.

COHERE Health increases $ 90 million in series C financing

Cohere Health, based in Boston, provides previous authorization solutions fueled by AI to help improve the relationship between payers and providers. It operates with around 600,000 suppliers and processes approximately 12 million previous permission requests each year.

The funding of $ 90 million was led by Temasek and included the support of Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital and Polaris Partners. It will help the company to evolve and invest in its AI products, according to the announcement. In total, Cohere Health raised $ 200 million.

Akido Labs obtains 60 million dollars in series B financing

Akido Labs, based in Los Angeles, is an AI and healthcare company. It offers a product called Scopeai, which helps suppliers diagnose patients, identify the most effective treatment and predict health risks.

The Tour of the S series B of $ 60 million was led by OAK HC / FT with the participation of GRECO, SNR, Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist of Google Deepmind and Google Research) and the complete blood and cancer center. Funding will help put its Scopeai product on the scale.

Sprinter Health hooks $ 55 million in series B financing

Sprinter Health, based in Menlo Park, California, works with health plans and offers home and virtual care. Its community health personnel, called Sprinters, and remote practitioner nurses provide diagnostic screening, vital controls, support for medication management, well-being visits and health navigation. Sprinters are W-2 employees and are certified in the form of phlebotomists and trained with skills by assisting medical and community health care.

The Tour of the 55 million dollars series was led by General Catalyst and included the participation of Andreessen Horowitz (A16z) Bio + Health, The Regents of the University of California, Google Ventures and Accel. Funding will help the company develop its team and extend to new geographic regions. Sprinter Health raised more than $ 125 million in total.

Phasev increases $ 50 million in series A series

Phasev, based in Boston, is a technological company that uses AI and automatic learning to help biopharmatic sponsors and contractual research organizations to make precise and effective clinical development decisions.

The company’s $ 50 million increase was co-directed by Accel and Insight Partners and included the participation of existing investors Viola Ventures, Exor and Lionbird. It will help the phasev “to develop its vertical AI platform to provide holistic solutions for clinical development”, according to the announcement. The company has raised $ 65 million in total.

Photo: Stockfinland, Getty Images

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button